News for Landos Biopharma, Inc. (LABP)

Dr. Lopez Brings 20+ Years of Global Clinical Development and Leadership to Support Atossa’s Mission in Developing Innovative Breast Cancer Therapies...

Advancements and Projections in the Pharmaceutical Intermediates Market: Insights, Trends, Opportunities, and Recent Developments...

Ventyx Biosciences appoints new interim finance chiefs

Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC)...

Cerevel Therapeutics presents a potential arbitrage opportunity with its acquisition by AbbVie, offering over 10% returns for investors. Read more on CERE stock.

NEW YORK, May 11, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Landos Biopharma, Inc. to AbbVie Inc. . Under the...

The dynamics of the inflammatory bowel disease market are anticipated to change in the coming years owing to the improvement in the diagnosis...

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and...

AbbVie outperformed expectations, with Humira remaining the market leader with 98% share despite LOE and biosimilar headwinds. Read more on ABBV stock here.

NEW YORK, March 25, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

BALA CYNWYD, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine manufacturer.

/PRNewswire/ -- DelveInsight's 'Rheumatoid Arthritis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

Read Investment Analysts’ Upgrades for May 24th (CAHPF, CCU, DNNGY, DOX, EOG, FNA, FREE, FXTGY, GBNH, GEGYY) at ETF Daily News

Read Equities Research Analysts’ Downgrades for May 21st (ASRT, CCNE, KOPN, KTB, KTOS, LABP, LSF, MASS, MDWD, MOR) at ETF Daily News

Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.